Accès gratuit
Colon Rectum
Volume 10, Numéro 1, Février 2016
Recommandations pour la pratique clinique - Cancer du rectum
Page(s) 4 - 11
Section Dossier Thématique / Thematic File
Publié en ligne 22 décembre 2015
  • Beets-Tan RG, Lambregts DM, Maas M, et al (2013) Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 23:2522–31 [CrossRef] [PubMed] [Google Scholar]
  • van de Velde CJ, Boelens PG, Borras JM, et al (2014) EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 50:1 e1–1 e34 [Google Scholar]
  • Brown G, Davies S, Williams GT, et al (2004) Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer 91:23–9 [CrossRef] [PubMed] [Google Scholar]
  • Beets-Tan R, Beets G (2004) Rectal cancer: revview with emphasis on MR imaging. Radiology 232:335–46 [CrossRef] [PubMed] [Google Scholar]
  • Samdani T, Garcia-Aguilar J (2014) Imaging in rectal cancer: magnetic resonance imaging versus endorectal ultrasonography. Surg Oncol Clin N Am 23:59–77 [CrossRef] [PubMed] [Google Scholar]
  • Monson JR, Weiser MR, Buie WD, et al: Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 56:535–50, 2013 [CrossRef] [PubMed] [Google Scholar]
  • van de Velde CJ, Aristei C, Boelens PG, et al (2013) EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 49:2784–90, [CrossRef] [PubMed] [Google Scholar]
  • Valentini V, Glimelius B, Haustermans K, et al (2014) EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review. Radiother Oncol 110:195–8 [CrossRef] [PubMed] [Google Scholar]
  • Sauer R, Becker H, Hohenberger W, et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–40 [CrossRef] [PubMed] [Google Scholar]
  • Sauer R, Liersch T, Merkel S, et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926–33 [CrossRef] [PubMed] [Google Scholar]
  • Peeters KC, Marijnen CA, Nagtegaal ID, et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701 [CrossRef] [PubMed] [Google Scholar]
  • van Gijn W, Marijnen CA, Nagtegaal ID, et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–82 [CrossRef] [PubMed] [Google Scholar]
  • Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–7 [CrossRef] [PubMed] [Google Scholar]
  • Frasson M, Garcia-Granero E, Roda D, et al (2011) Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 117:3118–25 [CrossRef] [PubMed] [Google Scholar]
  • Taylor FG, Quirke P, Heald RJ, et al (2011) Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone: A Prospective, Multicenter, European Study That Recruited Consecutive Patients With Rectal Cancer. Ann Surg 253:711–9 [CrossRef] [PubMed] [Google Scholar]
  • Gerard JP, Azria D, Gourgou-Bourgade S, et al (2012) Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 30:4558–65 [CrossRef] [PubMed] [Google Scholar]
  • Aschele C, Cionini L, Lonardi S, et al (2011) Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29:2773–80 [CrossRef] [PubMed] [Google Scholar]
  • O'Connell MJ, Colangelo LH, Beart RW, et al (2014) Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. J Clin Oncol 32:1927–34 [CrossRef] [PubMed] [Google Scholar]
  • Rodel C, Liersch T, Becker H, et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679–87 [CrossRef] [PubMed] [Google Scholar]
  • Schmoll HJ, Haustermans K, Price TJ, et al (2014) Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis. J Clin Oncol 32:3501 [Google Scholar]
  • Mohiuddin M, Winter K, Mitchell E, et al (2006) Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24:650–5 [CrossRef] [PubMed] [Google Scholar]
  • Hofheinz RD, Wenz F, Post S, et al (2012) Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13:579–88 [CrossRef] [PubMed] [Google Scholar]
  • Glimelius B, Tiret E, Cervantes A, et al (2013) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 Suppl 6:vi81–8 [CrossRef] [PubMed] [Google Scholar]
  • Kalady MF, de Campos-Lobato LF, Stocchi L, et al (2009) Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 250:582–9 [PubMed] [Google Scholar]
  • Petrelli F, Sgroi G, Sarti E, et al (2013) Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-Analysis of Published Studies. Ann Surg (in press) [Google Scholar]
  • Kapiteijn E, van De Velde CJ (2000) European trials with total mesorectal excision. Semin Surg Oncol 19:350–7 [CrossRef] [PubMed] [Google Scholar]
  • Pettersson D, Cedermark B, Holm T, et al (2010) Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97:580–7 [CrossRef] [PubMed] [Google Scholar]
  • Arbea L, Ramos LI, Martinez-Monge R, et al (2010) Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 5:17 [CrossRef] [PubMed] [Google Scholar]
  • Mok H, Crane CH, Palmer MB, et al (2011) Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol 6:63 [CrossRef] [PubMed] [Google Scholar]
  • Zhu J, Liu F, Gu W, et al (2014) Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study. Radiat Oncol 9:70 [CrossRef] [PubMed] [Google Scholar]
  • Marijnen CA, van de Velde CJ, Putter H, et al (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23:1847–58 [CrossRef] [PubMed] [Google Scholar]
  • Stephens RJ, Thompson LC, Quirke P, et al (2010) Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol 28:4233–9 [CrossRef] [PubMed] [Google Scholar]
  • Lange MM, Maas CP, Marijnen CA, et al (2008) Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 95:1020–8 [CrossRef] [PubMed] [Google Scholar]
  • Rahbari NN, Elbers H, Askoxylakis V, et al (2013) Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol 20:4169–82 [CrossRef] [PubMed] [Google Scholar]
  • Gerard JP, Azria D, Gourgou-Bourgade S, et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638–44 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.